Parcel Pal Technologies – On the Quick Road to Success
ParcelPal Technologies (CNSX: PKG) (OTCPK: PTNYF), a Canadian on-demand local delivery service provider, announced the completion of a major milestone of delivering over...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
Breaking New Ground with HEXWAVE, A Potential Game Changer in Weapon Detection
Liberty Defense Holdings (OTCPK: LDDFF), a pioneer in security solutions dealing with detection of concealed weapons in areas with high volume foot traffic,...
Fair Prospects ahead for Sirona Biochem with Grant of Key Patent for TFC-1067
Sirona Biochem (OTCPK: SRBCF), a biopharmaceutical company focused on discovering novel cosmetic and pharmaceutical compounds, announced the grant of a patent for TFC-1067,...
Gene Therapy offers Cure for Bubble Boy Syndrome
Severe combined immunodeficiency (SCID) or “Bubble Boy Syndrome” is a rare genetic disorder caused by gene mutations that inhibit the functioning of immune...
ReWalk Raises $5M for its ReStore Exosuit for Stroke Victims
Standing Tall ReWalk Robotics (NASDAQ: RWLK) recently received an approval for its ReStore exoskeleton system, indicated for rehabilitation of stroke victims, from the FDA. The...
The Emerging Paradigm in HIV Therapeutics Offers Hope for a Cure
Human Immunodeficiency Virus (HIV) compromises the body’s immunity by attacking CD4 cells (a type of T cell), exposing it to a host of...
Obalon Granted First US Patent for its Proprietary Intragastric Balloon System.
Obalon Therapeutics (NASDAQ: OBLN), the manufacturer of the first and only FDA-approved swallowable, gas-filled intragastric balloon system to combat obesity, has announced the...
Share Skyrockets on news of positive early-stage results from GEN-009 Clinical Trials
Genocea Biosciences, Inc. (NASDAQ: GNCA) skyrocketed today based on news of promising data from its early stage clinical trials of GEN-009, its neoantigen vaccine...
The Augmented Reality Company is on a roll with Major Deals in the Sports and Fitness Arena.
Imagination Park Technologies Inc. (CSE: IP) (OTCQB: IPNFF), an augmented reality (AR) platform, announced that it has acquired XenoHolographic. The transaction involved the transfer...
